PLA2G4B anticorps (AA 396-424)

N° du produit ABIN651112

Cet anticorps Lapin Polyclonal détecte spécifiquement PLA2G4B dans WB et FACS. Il présente une réactivité envers Humain.

Aperçu rapide pour PLA2G4B anticorps (AA 396-424) (ABIN651112)

Antigène: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G4B est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Clone: RB21321

Détail du produit anti-PLA2G4B anticorps

Épitope: AA 396-424

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This PLA2G4B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 396-424 amino acids from the Central region of human PLA2G4B.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. FC: 1:10~50

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Date de péremption: 6 months

Détails sur PLA2G4B

Antigène: PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))

Autre désignation: PLA2G4B

Sujet: PLA2G4B transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined.

Poids moléculaire: 87978

ID gène: 100137049

NCBI Accession: NP_001108105, NP_001185517, NP_005081

UniProt: P0C869

Pathways: ER-Nucleus Signaling, VEGF Signaling